scholarly journals Systematic review of behavioural smoking cessation interventions for older smokers from deprived backgrounds

BMJ Open ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. e032727
Author(s):  
Pamela Smith ◽  
Ria Poole ◽  
Mala Mann ◽  
Annmarie Nelson ◽  
Graham Moore ◽  
...  

IntroductionThe associations between smoking prevalence, socioeconomic group and lung cancer outcomes are well established. There is currently limited evidence for how inequalities could be addressed through specific smoking cessation interventions (SCIs) for a lung cancer screening eligible population. This systematic review aims to identify the behavioural elements of SCIs used in older adults from low socioeconomic groups, and to examine their impact on smoking abstinence and psychosocial variables.MethodSystematic searches of Medline, EMBASE, PsychInfo and CINAHL up to November 2018 were conducted. Included studies examined the characteristics of SCIs and their impact on relevant outcomes including smoking abstinence, quit motivation, nicotine dependence, perceived social influence and quit determination. Included studies were restricted to socioeconomically deprived older adults who are at (or approaching) eligibility for lung cancer screening. Narrative data synthesis was conducted.ResultsEleven studies met the inclusion criteria. Methodological quality was variable, with most studies using self-reported smoking cessation and varying length of follow-up. There were limited data to identify the optimal form of behavioural SCI for the target population. Intense multimodal behavioural counselling that uses incentives and peer facilitators, delivered in a community setting and tailored to individual needs indicated a positive impact on smoking outcomes.ConclusionTailored, multimodal behavioural interventions embedded in local communities could potentially support cessation among older, deprived smokers. Further high-quality research is needed to understand the effectiveness of SCIs in the context of lung screening for the target population.PROSPERO registration numberCRD42018088956.

Lung Cancer ◽  
2019 ◽  
Vol 135 ◽  
pp. 205-216 ◽  
Author(s):  
Christopher J. Cadham ◽  
Jinani C. Jayasekera ◽  
Shailesh M. Advani ◽  
Shelby J. Fallon ◽  
Jennifer L. Stephens ◽  
...  

Lung Cancer ◽  
2016 ◽  
Vol 98 ◽  
pp. 91-98 ◽  
Author(s):  
Bárbara Piñeiro ◽  
Vani N. Simmons ◽  
Amanda M. Palmer ◽  
John B. Correa ◽  
Thomas H. Brandon

2019 ◽  
Vol 121 ◽  
pp. 24-32 ◽  
Author(s):  
Jonathan M. Iaccarino ◽  
Celina Duran ◽  
Christopher G. Slatore ◽  
Renda Soylemez Wiener ◽  
Hasmeena Kathuria

Author(s):  
Christopher J Cadham ◽  
Pianpian Cao ◽  
Jinani Jayasekera ◽  
Kathryn L Taylor ◽  
David T Levy ◽  
...  

Abstract Background Guidelines recommend offering cessation interventions to smokers eligible for lung cancer screening, but there is little data comparing specific cessation approaches in this setting. We compared the benefits and costs of different smoking cessation interventions to help screening programs select specific cessation approaches. Methods We conducted a societal-perspective cost-effectiveness analysis using a Cancer Intervention and Surveillance Modeling Network model simulating individuals born in 1960 over their lifetimes. Model inputs were derived from Medicare, national cancer registries, published studies, and micro-costing of cessation interventions. We modeled annual lung cancer screening following 2014 US Preventive Services Task Force guidelines plus cessation interventions offered to current smokers at first screen, including pharmacotherapy only or pharmacotherapy with electronic and/or web-based, telephone, individual, or group counseling. Outcomes included lung cancer cases and deaths, life-years saved, quality-adjusted life-years (QALYs) saved, costs, and incremental cost-effectiveness ratios. Results Compared with screening alone, all cessation interventions decreased cases of and deaths from lung cancer. Compared incrementally, efficient cessation strategies included pharmacotherapy with either web-based cessation ($555 per QALY), telephone counseling ($7562 per QALY), or individual counseling ($35 531 per QALY). Cessation interventions continued to have costs per QALY well below accepted willingness to pay thresholds even with the lowest intervention effects and was more cost-effective in cohorts with higher smoking prevalence. Conclusion All smoking cessation interventions delivered with lung cancer screening are likely to provide benefits at reasonable costs. Because the differences between approaches were small, the choice of intervention should be guided by practical concerns such as staff training and availability.


2019 ◽  
pp. 225-242
Author(s):  
Meghan Cahill ◽  
Brooke Crawford O'Neill ◽  
Kimberly Del Mauro ◽  
Courtney Yeager ◽  
Bradley B. Pua

2015 ◽  
Vol 2 (2) ◽  
pp. 108
Author(s):  
Steven B Zeliadt ◽  
Jaimee L ◽  
Deborah E Klein ◽  
George Sayre ◽  
Lynn F Reinke ◽  
...  

2018 ◽  
Vol 40 (4) ◽  
pp. 526-534 ◽  
Author(s):  
Meytal S. Fabrikant ◽  
Juan P. Wisnivesky ◽  
Thomas Marron ◽  
Emanuela Taioli ◽  
Rajwanth R. Veluswamy

Sign in / Sign up

Export Citation Format

Share Document